Improved small cell lung cancer (SCLC) response rates with veliparib and temozolomide: Results from a phase II trial Meeting Abstract
| Authors: | Byers, L. A.; Krug, L.; Waqar, S.; Dowlati, A.; Hann, C.; Chiappori, A.; Owonikoko, T.; Woo, K.; Bensman, Y.; Hurtado, B.; Cardnell, R.; Diao, L.; Fan, Y.; Fujimoto, J.; Rodriguez-Canales, J.; Long, L.; Sulman, E.; Wistuba, I.; Wang, J.; Travis, W.; Chen, A.; Rudin, C.; Kris, M.; Fleisher, M.; Heymach, J.; Pietanza, M. C. |
| Abstract Title: | Improved small cell lung cancer (SCLC) response rates with veliparib and temozolomide: Results from a phase II trial |
| Meeting Title: | IASLC 17th World Conference on Lung Cancer |
| Keywords: | temozolomide; sclc; veliparib |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 12 |
| Issue: | 1 Suppl. |
| Meeting Dates: | 2016 Dec 4-7 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2017-01-01 |
| Start Page: | S406 |
| End Page: | S407 |
| Language: | English |
| ACCESSION: | WOS:000413055800447 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2016.11.466 |
| Notes: | Meeting Abstract: MA11.07 -- Source: Wos |
